Animal Experiment Reduction: Generative AI Promises to Enhance Efficiency and Ethics in Early Drug Development
Original framing: “Generative AI may significantly reduce the number of animal experiments” — Phys.org
Animal experimentation has a long and complex history, with various methods and approaches emerging over time. The development of alternative methods, such as in vitro testing and computer simulations, has been driven by growing concerns about animal welfare and the need for more humane research methods.
The integration of generative AI in early drug development phases has the potential to significantly reduce the number of animal experiments required, thereby enhancing efficiency and ethics in research.
However, this development also raises questions about the potential for AI to perpetuate existing power dynamics and biases, particularly if it is designed and implemented by those who do not prioritize animal welfare or indigenous perspectives. To mitigate these risks, researchers and policymakers must prioritize marginalized voices, invest in alternative methods, and work towards a more compassionate and respectful approach to animal experimentation. By doing so, they can create a more just and equitable research environment that prioritizes the welfare of all living beings.